ID27048A - Metode untuk mencegah mrp1 - Google Patents

Metode untuk mencegah mrp1

Info

Publication number
ID27048A
ID27048A IDW20002009A ID20002009A ID27048A ID 27048 A ID27048 A ID 27048A ID W20002009 A IDW20002009 A ID W20002009A ID 20002009 A ID20002009 A ID 20002009A ID 27048 A ID27048 A ID 27048A
Authority
ID
Indonesia
Prior art keywords
mrp1
prevent
prevent mrp1
Prior art date
Application number
IDW20002009A
Other languages
English (en)
Indonesian (id)
Inventor
Joseph Michael Gruber
Bryan H Norman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27048A publication Critical patent/ID27048A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20002009A 1998-04-08 1999-04-07 Metode untuk mencegah mrp1 ID27048A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8107798P 1998-04-08 1998-04-08

Publications (1)

Publication Number Publication Date
ID27048A true ID27048A (id) 2001-02-22

Family

ID=22161958

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002009A ID27048A (id) 1998-04-08 1999-04-07 Metode untuk mencegah mrp1

Country Status (17)

Country Link
US (1) US6417193B1 (no)
EP (1) EP1069897A1 (no)
JP (1) JP2002510624A (no)
KR (1) KR20010042482A (no)
CN (1) CN1296408A (no)
AU (1) AU3468099A (no)
BR (1) BR9909497A (no)
CA (1) CA2327706A1 (no)
EA (1) EA200001036A1 (no)
HU (1) HUP0101736A3 (no)
ID (1) ID27048A (no)
IL (1) IL138391A0 (no)
NO (1) NO20005042D0 (no)
PL (1) PL343312A1 (no)
SK (1) SK15002000A3 (no)
TR (1) TR200002803T2 (no)
WO (1) WO1999051227A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2395513A1 (en) * 1999-12-22 2001-06-28 Rosanne Bonjouklian Methods and compounds for inhibiting mrp1
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
WO2001096346A1 (en) * 2000-06-14 2001-12-20 Eli Lilly And Company Tricyclic compounds as mrp1-inhibitors
CA2413579A1 (en) 2000-06-23 2002-01-03 Eli Lilly And Company Methods and compounds for inhibiting mrp1
WO2002024705A1 (en) * 2000-09-22 2002-03-28 Eli Lilly And Company Stereoselective process for preparing cyclohexyl amine derivatives
WO2002081482A1 (en) * 2001-04-09 2002-10-17 Eli Lilly And Company Compounds and methods for inhibiting mrp1
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
CN104002843A (zh) * 2014-05-29 2014-08-27 安徽银龙泵阀股份有限公司 一种减震效果好易于放置的双泵移动车

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5717092A (en) 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity

Also Published As

Publication number Publication date
CN1296408A (zh) 2001-05-23
NO20005042L (no) 2000-10-06
TR200002803T2 (tr) 2000-12-21
EP1069897A1 (en) 2001-01-24
HUP0101736A3 (en) 2002-04-29
JP2002510624A (ja) 2002-04-09
WO1999051227A1 (en) 1999-10-14
CA2327706A1 (en) 1999-10-14
NO20005042D0 (no) 2000-10-06
US6417193B1 (en) 2002-07-09
EA200001036A1 (ru) 2001-04-23
BR9909497A (pt) 2000-12-12
KR20010042482A (ko) 2001-05-25
IL138391A0 (en) 2001-10-31
PL343312A1 (en) 2001-08-13
SK15002000A3 (sk) 2001-06-11
HUP0101736A2 (hu) 2001-11-28
AU3468099A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
IS8368A (is) Ný aðferð
ID26007A (id) Proses karbonilasi
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
ATE269861T1 (de) Substituierte indolalkansäure
ID23234A (id) Turunan-turunan benzosulfona
ID27484A (id) Turunan adenosina
ID23287A (id) Trisiklik tersubstitusi
ID27547A (id) Turunan kuinolin
ID23458A (id) Bentuk sediaan nefazodon
ID23316A (id) Proses karbonilasi
ID22098A (id) Metode menghilangkan coret-coretan
IS5106A (is) Ný aðferð
ID28966A (id) Metoda pemurnian trietanolamina
ID23219A (id) Trisiklik tersubstitusi
DE59905139D1 (de) Strukturelement
ID27364A (id) Metode untuk menghambat mrp1
ID27048A (id) Metode untuk mencegah mrp1
ID28356A (id) Turunam tiazola
ID26804A (id) Metode untuk menghambat mrp1
DE59912188D1 (de) Substituierte phenyluracile
DE59912532D1 (de) Substituierte acylaminophenyl-uracile
DE59911610D1 (de) Substituierte benzoylcyclohexandione
DE69931682D1 (de) Verbrennungsmethode
PT1076660E (pt) (4-bromopirazol-3-il)-benzazolos substituidos